Celadon

CEL.L

Tags: GB Healthcare Drug Manufacturers - Specialty & Generic

Celadon Pharmaceuticals Plc Price (CEL.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

61,893,906

(8.0266)%

Market Cap of Celadon (CEL.L)

Market cap:

As of , CEL.L has a market cap of . This makes CEL.L the 1059th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $11-122.5
Market Cap 9.64M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. James Gareth Short
IPO Date: March, 31, 2022
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 27

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: